Overview

This trial is active, not recruiting.

Conditions shortness of breath, acute exacerbation
Sponsor Hillel Yaffe Medical Center
Start date October 2005
End date September 2007
Trial size 500 participants
Trial identifier NCT00271128, hymc34/2005

Summary

The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: 1. Acute shortness of breath of unknown etiology as presentation to the emergency room 2. Possible acute exacerbation of known heart failure Exclusion Criteria: None -

Additional Information

Official title NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward (BNP4EVER)
Principal investigator Simcha R Meisel, MD MSc
Description The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards. Patients will be consented and randomized to open or blinded NT-proBNP test performed within 90 minutes in a venous blood sample. Evaluation of the ER diagnosis and final discharge diagnosis in admitted patients will be carried out in light of the NT-proBNP results.
Trial information was received from ClinicalTrials.gov and was last updated in March 2008.
Information provided to ClinicalTrials.gov by Hillel Yaffe Medical Center.